Exploring the Spiritual Dimensions of Psychedelics

Updated June 2026 · Last reviewed for accuracy and compliance.

Important notice — please read first

Classical psychedelics including psilocybin, LSD, DMT and mescaline are controlled substances in the UK and across most EU member states. This article is an educational summary of published research and historical context for informational purposes only. It is not a guide to obtaining or using any controlled substance outside an authorised clinical research setting. Canna Health Amsterdam does not sell controlled psychedelic substances and does not encourage their unauthorised use. If you have a mental health concern, please speak with a qualified clinician.

Exploring the spiritual dimensions of psychedelics is a topic where ethnographic, historical, philosophical and modern research traditions converge. Across many cultures and across centuries, psychedelic compounds — whether the peyote of the Wixárika, ayahuasca of the Upper Amazon, psilocybin mushrooms of Mesoamerican traditions, or Soma of Vedic literature — have appeared within frameworks that combine therapeutic, ritual and spiritual elements. This article surveys those traditions briefly, discusses how the modern research literature engages with the spiritual dimension, and outlines what an informed reader should keep in mind. It is informational and educational only.

Spiritual dimensions of psychedelics — Canna Health Amsterdam educational overview

Historical and cultural context

Indigenous and traditional use of psychedelic compounds in spiritual frameworks is documented across many cultures: the use of psilocybin mushrooms in pre-Columbian Mesoamerican religious life; ayahuasca traditions in the Upper Amazon; peyote in the religion of the Wixárika (Huichol) people of Mexico and in the Native American Church; iboga in Bwiti tradition in Central Africa; Soma in Vedic literature (subject of long scholarly debate over its botanical identity). Reading on the ethnobotany: PubMed — psychedelic ethnobotany.

How modern research engages with the spiritual

Modern clinical psychedelic research has, somewhat unusually, included explicit measurement of what researchers call ‘mystical-type experiences’. Roland Griffiths’s programme at Johns Hopkins used psychometric instruments designed to capture this dimension, and findings published in Griffiths et al., 2006, Psychopharmacology reported that participants in psilocybin sessions described experiences that they rated, months later, as among the most personally significant of their lives. Subsequent research has explored the relationship between these experience characteristics and clinical outcomes in indications like depression, addiction and end-of-life distress.

Why the spiritual dimension is contested

There is genuine scholarly debate about how to interpret ‘mystical-type’ experiences. Different researchers and different traditions read them differently — as genuine encounters with a transcendent reality (in some religious framings), as constructed psychological events with significant therapeutic implications (in some clinical framings), as neurological phenomena to be characterised mechanistically (in some neuroscience framings), or as combinations of these. The frameworks are not necessarily mutually exclusive but reading any one of them as the definitive interpretation is a category error.

Regulatory and safety reality

Whatever framings appeal to a reader, the regulatory reality remains: classical psychedelics are controlled substances in the UK and across most EU member states. Spiritual framings do not change that legal position. Religious-use exemptions exist in some jurisdictions for specific traditional contexts (Native American Church peyote use in the US, ayahuasca for Santo Daime and União do Vegetal in some jurisdictions) but do not extend to general consumer use.

FAQs — spiritual dimensions of psychedelics

Are psychedelics legal for religious or spiritual use?

Some specific exemptions exist (e.g., Native American Church peyote in the US, ayahuasca for specific Brazilian-origin churches in some jurisdictions). General consumer use remains controlled. Verify your local position.

Does the research recognise spiritual dimensions?

Modern clinical psychedelic research has measured ‘mystical-type experiences’ using psychometric instruments. The findings are robust enough that researchers consider the experience character to be relevant to clinical outcomes.

How should one interpret mystical-type experiences?

There is genuine scholarly debate. Different traditions read them differently. Reading any single framing as definitive is a category error.

Where can I read the research?

Indexed: PubMed — psilocybin and mystical experience.

Does Canna Health Amsterdam sell psychedelics?

No.

All consumer products sold by Canna Health Amsterdam are food supplements or cosmetics. Information current to June 2026.